Welcome to our dedicated page for Research Solutions news (Ticker: RSSS), a resource for investors and traders seeking the latest updates and insights on Research Solutions stock.
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI company that focuses on research workflows and scientific, technical, and medical (STM) content. This news page aggregates company-issued press releases and other coverage so readers can follow how Research Solutions develops its platforms, reports financial performance, and communicates with investors.
Recent news highlights the company’s positioning as an AI-powered research workflow platform serving academic institutions, life science companies, and research organizations worldwide. Articles describe the growth of its platform revenue and annual recurring revenue, as well as its emphasis on metrics such as Adjusted EBITDA and gross margin as it shifts more of its business toward SaaS and AI solutions.
Readers can expect updates on earnings releases and financial results, where the company reports revenue from its platforms and transactions, discusses ARR trends across B2B and B2C subscriptions, and comments on its progress toward goals such as a Rule of 40 framework. News items also cover product and feature launches, including AI-based offerings like Scite Rankings and the AI Rights add-on for Article Galaxy, which the company describes as addressing compliance needs around AI use of scientific literature.
Additional coverage includes corporate and governance developments, such as management changes, conference presentations, and information about upcoming earnings calls. Investors, researchers, and customers who follow RSSS news can use this page to monitor how the company’s SaaS platforms, AI capabilities, and financial profile evolve over time. For ongoing analysis, users may wish to revisit this page as new press releases and filings are published.
Research Solutions (NASDAQ: RSSS) has launched Curedatis, a SaaS platform aimed at streamlining literature review workflows for medical device companies. This innovative tool enhances the clinical evaluation process by enabling rapid article screening and maintaining regulatory compliance through intelligent documentation. Key features include simplified searching, ultra-fast screening utilizing PICO terms, and centralized article access via the Article Galaxy platform, which reduces time spent on data duplication. Curedatis addresses critical challenges in clinical evaluations for healthcare professionals.
Research Solutions, Inc. (NASDAQ: RSSS) has announced the acquisition of selected customer contracts from FIZ Karlsruhe's AutoDoc service, which serves approximately 700 global customers. This strategic move is expected to enhance transaction revenues and provide opportunities to cross-sell to the Article Galaxy Platform. The contract assumption will take effect on January 1, 2023, with revenue recognition starting in the fiscal third quarter. The acquisition aims to expand Research Solutions' customer base and geographic reach, aligning with their strategy for greater recurring revenue and business growth.
Research Solutions, Inc. (NASDAQ: RSSS) reported a 4% increase in total revenue to $8.6 million for Q4 FY2022, driven by a 32% rise in platform revenue, reaching $1.9 million. The company achieved a 35% increase in annual recurring revenue (ARR), totaling $7.9 million, and added 53 net new platform deployments. Despite these gains, Research Solutions recorded a net loss of $438,000, translating to $0.02 per share, and a negative adjusted EBITDA of $121,000. For the fiscal year, total revenue grew to $32.9 million, but net loss widened to $1.6 million.
Research Solutions, Inc. (NASDAQ: RSSS) is scheduled to announce its fourth quarter and full fiscal year results for the period ending June 30, 2022, on September 22, 2022. The conference call will be hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen at 5:00 p.m. ET. Interested parties can join the call or access it via the investor relations section of the company's website afterward. Research Solutions provides cloud-based technologies focused on research and development, serving over 70% of top pharmaceutical companies and universities.
Research Solutions, Inc. (NASDAQ: RSSS) will participate in the Midwest IDEAS Investor Conference on August 25, 2022. President & CEO Roy W. Olivier and CFO Bill Nurthen are scheduled to host investor meetings, with their presentation set for 11:15 am ET. The event will be accessible via webcast at Three Part Advisors. Founded in 2006, Research Solutions offers cloud-based technologies for managing intellectual property, serving over 70% of leading pharmaceutical companies and universities.
Research Solutions, Inc. (NASDAQ: RSSS) will participate in the East Coast IDEAS Investor Conference on June 22, 2022. The presentation will be available at 6:00 am ET, accessible via the conference website. Roy W. Olivier, President & CEO, and Bill Nurthen, CFO, will represent the company. Established in 2006, Research Solutions provides cloud-based technologies for managing intellectual property and serves over 70% of top pharmaceutical firms and universities through its Article Galaxy platform. For further participation details, contact Steven Hooser.
Research Solutions, Inc. (NASDAQ: RSSS) announced record revenue of $8.8 million for Q3 2022, marking a 5% increase year-over-year. The company's Annual Recurring Revenue (ARR) rose by 32% to $7.3 million, driven by strong platform growth and 34 new platform deployments. Despite these gains, the company reported a net loss of $341,000, or $0.01 per share, compared to breakeven a year ago. Adjusted EBITDA decreased to $94,000 from $238,000. Total gross margin improved to 37% from 32.4% last year, reflecting a favorable revenue mix.
Research Solutions, Inc. (NASDAQ: RSSS) will announce its fiscal third quarter results for the period ended March 31, 2022, on May 12, 2022, at 5:00 p.m. ET. A press release with financial results will precede the call. The conference will be led by CEO Roy W. Olivier and CFO Bill Nurthen, followed by a Q&A session. Investors can participate via toll-free and international dial-in numbers. A replay will be available until June 12, 2022. Research Solutions specializes in cloud-based technologies for R&D organizations, with over 70% of top pharmaceutical companies utilizing its Article Galaxy platform.
Research Solutions (NASDAQ: RSSS) will participate in the 2022 Virtual Growth Conference on March 29th at 1:00 p.m. ET. Hosted by Maxim Group LLC and M-Vest, the event will feature presentations, fireside chats, and live Q&A sessions with CEOs. Research Solutions, known for its cloud-based technologies, serves over 70% of top pharmaceutical companies and universities with its SaaS platform, Article Galaxy, designed to streamline access to scientific research. For participation, sign up at m-vest.com/events.
Research Solutions (NASDAQ: RSSS) announced a partnership with scite to enhance its cloud-based research tools, Bibliogo and Article Galaxy. This collaboration aims to display Smart Citations, allowing users to easily identify the context of citations and whether they support or contrast with the articles in question. This initiative is designed to streamline access to crucial research, benefiting both customers and researchers by improving the efficiency of discovering relevant studies. The partnership underscores Research Solutions' commitment to simplifying the research process.